Skip to content

Efficacy of balloon Eustachian tuboplasty

Efficacy of balloon Eustachian tuboplasty - prospective, blinded and placebo-controlled multi-centre study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN50406162
Enrollment
165
Registered
2017-11-23
Start date
2017-11-27
Completion date
Unknown
Last updated
2022-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent secretory otitis media, severe symptoms of ETD or baro-challenged ETD Ear, Nose and Throat Nonsuppurative otitis media, unspecified

Interventions

Parallel-group randomisation is made after local anaesthesia induction before the operation. Patients are treated with either BET or sham surgery under local anaesthesia. The patients are blinded to t

Sponsors

Helsinki University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All patients in this study suffer from dilatory Eustachian tube dysfunction and are deemed suitable for BET. Possible indications are: 1. Persistent secretory otitis media 2. Severe symptoms of ETD 3. Baro-challenged ETD

Exclusion criteria

Exclusion criteria: 1. The occurrence of cleft palate in any form 2. Current ventilating grommet 3. Tympanic membrane perforation 4. Adhesive otitis 5. Cholesteatoma 6. Cystic fibrosis 7. Immotile cilia syndrome 8. Untreated nasal polyposis 9. Samter's triade 10. Untreated gastroesophageal reflux disease 11. Other mechanical obstruction in nasopharynx

Design outcomes

Primary

MeasureTime frame
Measured at baseline, 3 months and 1 year: 1. Valsalva maneuver based on physicians descriptive findings 2. Otomicroscopy based on physicians descriptive findings 3. Tympanometry results classified as A, B and C type outcomes 4. Tubomanometry results based on the Eustachian tube opening and opening latency index 5. Need for grommets

Secondary

MeasureTime frame
Quality of life measured with disease specific questionnaire ETDQ7 at baseline, 3 months and 1 year

Countries

Finland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026